A Uk Based Cost-Effectiveness Analysis Of Glycopyrronium Bromide A New Anti-Muscarinic Agent For The Maintenance Treatment Of Patients With COPD

被引:0
|
作者
Malcolm, W. A. [1 ]
Keyzor, I. [1 ]
Radwan, A. [1 ]
Price, D. B. [2 ]
Asukai, Y. [3 ]
Ananthapavan, J. [3 ]
机构
[1] Novartis Pharmaceut, Frimley, England
[2] Univ Aberdeen, Aberdeen, Scotland
[3] IMS Hlth, London, England
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2156
引用
收藏
页数:1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF BIRTH COHORT SCREENING AND TREATMENT FOR HCV IN THE UK: AN EXPLORATORY ANALYSIS
    Selvapatt, N.
    Ward, T.
    Ananthavarathan, A.
    Khan, B.
    Webster, S.
    Thursz, M.
    Brown, A.
    McEwan, P.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S465 - S465
  • [42] Cost-effectiveness Analysis of Aripiprazole Once-Monthly for the Treatment of Schizophrenia in the UK
    Tempest, Michael
    Sapin, Christophe
    Beillat, Maud
    Robinson, Paul
    Treur, Maarten
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2015, 18 (04): : 185 - 200
  • [43] Cost-effectiveness analysis of rituximab as a new therapeutic option for rheumatoid arthritis in the UK
    Porter, D
    Lewis, G
    Brown, B
    Diamantopoulos, A
    Kielhorn, A
    VALUE IN HEALTH, 2006, 9 (03) : A25 - A25
  • [44] Cost-effectiveness of Roflumilast in the UK: A 1-year study in patients with severe to very severe COPD
    Van Nooten, F.
    Rutten-Van Molken, M.
    Lindemann, M.
    Sandtmann, R.
    VALUE IN HEALTH, 2006, 9 (06) : A260 - A261
  • [45] Cost-effectiveness analysis of azacitidine maintenance therapy in patients with acute myeloid leukemia
    Zhu, Jinbing
    Wu, Qiuji
    Wang, Jinjin
    Niu, Ting
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (04) : 375 - 382
  • [46] A UK based cost-utility analysis of indacaterol - A once-daily maintenance bronchodilator for patients with COPD
    Asukai, Yumi
    Ananthapavan, Jaithri
    Malcolm, Bill
    Radwan, Amr
    Keyzor, Ian
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [47] Treatment of ascites in patients with cirrhosis: A cost-effectiveness analysis.
    Gines, P
    Uriz, J
    Trilla, A
    Blei, A
    Cardenas, A
    Ortega, R
    Calahorra, B
    Arroyo, V
    Asenjo, M
    Rodes, J
    HEPATOLOGY, 2001, 34 (04) : 549A - 549A
  • [48] COST-EFFECTIVENESS ANALYSIS OF TIOTROPIUM BROMIDE FOR PATIENTS WITH SEVERE OBSTRUCTIVE PULMONARY DISEASE IN MEXICO
    Herran, S.
    Baez-Revueltas, F. B.
    Peniche Otero, G.
    Herrera Rojas, J.
    Baeza, G.
    VALUE IN HEALTH, 2016, 19 (03) : A115 - A115
  • [49] Intervention thresholds for denosumab in the UK using a FRAX®-based cost-effectiveness analysis
    O. Ström
    B. Jönsson
    J. A. Kanis
    Osteoporosis International, 2013, 24 : 1491 - 1502
  • [50] Optimized Maintenance Standards for Unpaved Road Networks Based on Cost-Effectiveness Analysis
    Chamorro, Alondra
    Tighe, Susan L.
    TRANSPORTATION RESEARCH RECORD, 2015, (2473) : 56 - 65